No abstract

The high-concentration stable dispersion of free-standing mono- or few-layer transition metal dichalcogenide (TMD) nanosheets (NSs) remains a significant barrier for their application in solution-processed optoelectronic devices. Here, we report oleylamine (OLA)- and dodecanethiol (DDT)-assisted exfoliation of MoS NSs in nonpolar organic solvent 1,2-dichlorobenzene (DCB), which enables high-concentration stable dispersion of free-standing mono- or few-layer NSs. The functionalized MoS NSs were further utilized for the fabrication of solution-processed 0D-2D hybrids of CuInS quantum dots (CIS QDs) and MoS NSs. The strong photoluminescence (PL) quenching and decreased PL lifetimes of CIS QDs attached to MoS NSs indicates efficient charge transfer from photoexcited CIS to MoS NSs. The photocurrent of CIS/MoS hybrid devices is dramatically enhanced compared to that of pure CIS and pristine MoS-based devices, confirming that efficient charge separation and transfer occur from CIS QDs to MoS NSs.

The ongoing coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China, was triggered and unfolded quickly throughout the globe by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The new virus, transmitted primarily through inhalation or contact with infected droplets, seems very contagious and pathogenic, with an incubation period varying from 2 to 14 days. The epidemic is an ongoing public health problem that challenges the present global health system. A worldwide social and economic stress has been observed. The transitional source of origin and its transport to humans is unknown, but speedy human transportation has been accepted extensively. The typical clinical symptoms of COVID-19 are almost like colds. With case fatality rates varying from 2 to 3 percent, a small number of patients may experience serious health problems or even die. To date, there is a limited number of antiviral agents or vaccines for the treatment of COVID-19. The occurrence and pathogenicity of COVID-19 infection are outlined and comparatively analyzed, given the outbreak’s urgency. The recent developments in diagnostics, treatment, and marketed vaccine are discussed to deal with this viral outbreak. Now the scientist is concerned about the appearance of several variants over the globe and the efficacy of the vaccine against these variants. There is a need for consistent monitoring of the virus epidemiology and surveillance of the ongoing variant and related disease severity.

No abstract